ADPT - Company ID 0001478320
The table below shows Adaptive Biotechnologies Corp's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $75.61M | $169.87M | $77.58M | $55.03M | $43.16M | $50.65M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $66.67M | $49.51M | $48.31M | $44.82M | $44.28M | $43.58M |
| Inventory | $10.05M | $10.50M | $11.21M | $9.93M | $8.40M | $8.68M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $392.69M |
| $420.56M |
| $291.81M |
| $281.44M |
| $261.86M |
| $256.49M |
| Property, plant & equipment | $27.97M | $29.45M | $30.77M | $37.50M | $41.05M | $44.43M |
| Goodwill | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M | $118.97M |
| Total assets | $683.12M | $640.68M | $505.94M | $490.61M | $496.64M | $510.85M |
| Accounts payable | $6.53M | $5.24M | $9.62M | $10.27M | $6.91M | $6.36M |
| Total current liabilities | $98.97M | $87.71M | $87.01M | $83.36M | $92.14M | $87.81M |
| Long-term debt | $0.00 | $0.00 | $124.75M | $129.41M | $130.50M | $131.55M |
| Total liabilities | $499.23M | $490.02M | $281.70M | $286.36M | $317.10M | $320.63M |
| Retained earnings | -$1.42B | -$1.42B | -$1.38B | -$1.35B | -$1.36B | -$1.33B |
| Total equity | $176.21M | $142.91M | $216.34M | $204.44M | $179.72M | $190.42M |